|Appears in Collections:||Aquaculture Journal Articles|
|Peer Review Status:||Refereed|
|Title:||Europe’s first and last field trial of gene-edited plants?|
Napier, Johnathan A
|Keywords:||General Biochemistry, Genetics and Molecular Biology|
General Immunology and Microbiology
|Citation:||Faure J & Napier JA (2018) Europe’s first and last field trial of gene-edited plants?. eLife, 7, Art. No.: e42379. https://doi.org/10.7554/elife.42379|
|Abstract:||On 5 June this year the first field trial of a CRISPR-Cas-9 gene-edited crop began at Rothamsted Research in the UK, having been approved by the UK Department for Environment, Food & Rural Affairs. However, in late July 2018, after the trial had started, the European Court of Justice ruled that techniques such as gene editing fall within the European Union's 2001 GMO directive, meaning that our gene-edited Camelina plants should be considered as genetically modified (GM). Here we describe our experience of running this trial and the legal transformation of our plants. We also consider the future of European plant research using gene-editing techniques, which now fall under the burden of GM regulation, and how this will likely impede translation of publicly funded basic research|
|Rights:||Copyright Faure and Napier. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.|
|elife-42379-v1.pdf||Fulltext - Published Version||640.82 kB||Adobe PDF||View/Open|
This item is protected by original copyright
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
If you believe that any material held in STORRE infringes copyright, please contact email@example.com providing details and we will remove the Work from public display in STORRE and investigate your claim.